Skip to main content

BMY

Insider Trading

Bristol Myers Squibb

Health Care / Pharmaceuticals

Recent Insider Transactions

Source: SEC Form 4 filings. Updated daily. Transaction codes: P = Open-Market Purchase, S = Open-Market Sale, F = Tax Withholding, A = Award, M = Option Exercise.

DateReporterTypeSharesPriceTotal Value
May 5, 2026
Lenkowsky Adam
EVP, Chief Commercial Officer
MOption Exercise
1,373$0.00$0.00
Apr 2, 2026
YALE PHYLLIS R
AAward
577.08$60.65$35K
Apr 2, 2026
Rice Derica W
AAward
638.91$60.65$39K
Apr 2, 2026
Elkins David V
EVP, Chief Financial Officer
SOpen-Market Sale10b5-1
30,000$61.67$1.9M
Apr 2, 2026
Shanahan Karin
EVP, Chief Supply Chain & Ops
MOption Exercise
3,307$0.00$0.00
Apr 2, 2026
Samuels Theodore R. II
AAward
845.01$60.65$51K
Apr 2, 2026
Arduini Peter J
AAward
577.08$60.65$35K
Apr 2, 2026
McMullen Michael R.
AAward
577.08$60.65$35K
Mar 3, 2026
Hickey Benjamin
President, RayzeBio Org.
MOption Exercise
3,286$0.00$0.00

Get BMY insider alerts in your inbox

The Filing Cabinet tracks SEC Form 4 filings for every S&P 500 company and delivers a free daily digest of the most significant insider trades.